Identifying New Therapeutic Targets via Modulation of Protein Corona Formation by Engineered Nanoparticles

• Rochelle R. Arvizo,

  Affiliation Department of Biochemistry and Molecular Biology, Mayo Clinic College of Medicine, Rochester, Minnesota, United States of America

  ⨯
• Karuna Giri,

  Affiliation Department of Biochemistry and Molecular Biology, Mayo Clinic College of Medicine, Rochester, Minnesota, United States of America

  ⨯
• Daniel Moyano,

  Affiliation Department of Chemistry, University of Massachusetts, Amherst, Massachusetts, United States of America

  ⨯
• Oscar R. Miranda,

  Affiliation Department of Chemistry, University of Massachusetts, Amherst, Massachusetts, United States of America

  ⨯
• Benjamin Madden,

  Affiliation Proteomics Research Center, Mayo Clinic College of Medicine, Rochester, Minnesota, United States of America

  ⨯
• Daniel J. McCormick,

  Affiliation Proteomics Research Center, Mayo Clinic College of Medicine, Rochester, Minnesota, United States of America

  ⨯
• Resham Bhattacharya,

  Affiliation Department of Biochemistry and Molecular Biology, Mayo Clinic College of Medicine, Rochester, Minnesota, United States of America

  ⨯
• Vincent M. Rotello,

  Affiliation Department of Chemistry, University of Massachusetts, Amherst, Massachusetts, United States of America

  ⨯
• Jean-Pierre Kocher,

  Affiliation Biomedical Statistics and Informatics, Mayo Clinic College of Medicine, Rochester, Minnesota, United States of America

  ⨯
• Priyabrata Mukherjee

  * E-mail: Mukherjee.priyabrata@mayo.edu

  Affiliations Department of Biochemistry and Molecular Biology, Mayo Clinic College of Medicine, Rochester, Minnesota, United States of America, Department of Physiology and Biomedical Engineering, Mayo Clinic College of Medicine, Rochester, Minnesota, United States of America, Mayo Clinic Cancer Center, Mayo Clinic College of Medicine, Rochester, Minnesota, United States of America

  ⨯